Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A reliable method was created to measure dutasteride and related molecules in capsules.

MK-5108 is safe and shows potential against tumors, especially alone.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Surgery and antifungal medication are effective for treating Merkel cell carcinoma with fungal infection.

MK-386 reduces sebum DHT levels.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

The N-K GM Series offers highly selective, eco-friendly antimicrobials free for everyone.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

Mdm2 is crucial for controlling p53 to maintain healthy cells and prevent tumors.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Suppressing ODC activity reduces tumor growth in hair follicles.

GSDMA deficiency slows skin cancer growth.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

MK-386 lowers DHT in blood and skin but not in semen.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.